BackTelix Pharmaceuticals Limited Overview

Telix Pharmaceuticals Limited Goodwill

Telix Pharmaceuticals Limited's goodwill is $200M.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$197.43M
↑ 5.70% YoYΔ $10.65M vs prior year quarter

Peer trimmed avg / median

Loading

Telix Pharmaceuticals Limited Goodwill History

Loading

Telix Pharmaceuticals Limited vs. peers: Goodwill Comparison

Loading

Telix Pharmaceuticals Limited Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Telix Pharmaceuticals Limited (TLX) FAQ

The latest goodwill for TLX is $200M as of June 2026. That compares with $190M in the prior-year period — up 5.7% year over year. Investors often review this figure alongside Telix Pharmaceuticals Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, TLX's goodwill moved from $190M to $200M — a 5.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Telix Pharmaceuticals Limited's operating scale or balance-sheet position.

A goodwill figure of $200M for TLX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting TLX's goodwill ($200M), review year-over-year change from $190M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Telix Pharmaceuticals Limited's goodwill against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.

Questions & Answers